Newsroom - TRB Chemedica International

Filters

Watch the video of the conference “L’homme cérébral” that took place on March 13, 2021 (past event)

Learn More

Our new Swiss website is now live, find out more about TRB products for Switzerland (past event)

Learn More

Strong scientific presence of TRB at WCO IOF-ESCEO virtual congress 2020 (past event)

Learn More

COVID-19, how we adapt and respond to the situation.

Learn More

Publication of a clinical trial evaluating Ostenil Plus in osteoarthritis

Learn More

TRB Chemedica International S.A. and InnoMedica Holding AG enter in a long-term relationship regarding the production of GM1 (monosialotetrahexosylganglioside) and its development as a liposomal formulation under the trade name Talineuren®

TRB Chemedica announces a collaboration with InnoMedica to develop liposomal GM1

Learn More

You are about to leave the TRB corporate website. This link will take you to a local TRB website. Medical practices and regulations can be different from one country to another.

As a result, the medical information provided in the site which you are going to visit may not be appropriate for product use in your country.

CONTINUE